ARIL Trademark

Trademark Overview

On Wednesday, February 25, 2015, a trademark application was filed for ARIL with the United States Patent and Trademark Office. The USPTO has given the ARIL trademark a serial number of 86545755. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, February 6, 2025. This trademark is owned by Seed Biotech, Inc.. The ARIL trademark is filed in the Pharmaceutical Products category with the following description:

Acellular amniotic membrane allograft tissue
aril

General Information

Serial Number86545755
Word MarkARIL
Filing DateWednesday, February 25, 2015
Status800 - REGISTERED AND RENEWED
Status DateThursday, February 6, 2025
Registration Number4830887
Registration DateTuesday, October 13, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2015

Trademark Statements

Goods and ServicesAcellular amniotic membrane allograft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2015
Primary Code005
First Use Anywhere DateTuesday, October 1, 2013
First Use In Commerce DateTuesday, October 1, 2013

Trademark Owner History

Party NameSeed Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChattanooga, TN 37415
Party NameSeed Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75226
Party NameSeed Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75226

Trademark Events

Event DateEvent Description
Tuesday, June 2, 2015ASSIGNED TO EXAMINER
Thursday, June 4, 2015EXAMINERS AMENDMENT E-MAILED
Saturday, February 28, 2015NEW APPLICATION ENTERED
Wednesday, March 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 4, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, June 4, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 4, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, October 13, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 22, 2015ASSIGNED TO LIE
Monday, June 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 28, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2015REGISTERED-PRINCIPAL REGISTER
Monday, January 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, October 13, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, October 14, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 26, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, January 26, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, February 10, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, February 10, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, October 13, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, February 6, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 6, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, February 6, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, February 6, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

aril tissue allograft membrane amniotic acellular